Table 4.

In each of 11 experiments, 20 top-ranked significant KEGG pathways whose associated genes significantly match some genes selected for each experiment were identified. Thus, the following KEGG pathways are most frequently ranked within the top 20.

Exp.	#	(i)	(ii)	(iii)	(iv)	(v)	(vi)	(vii)	(viii)	(ix)	(x)
1	(232)	31/137	7/168	10/142	6/133	9/55	9/193			7/169	8/203
	[10]	$3.69\times {10}^{29}$	$3.18\times {10}^2$	$1.66\times {10}^4$	$3.45\times {10}^2$	$1.02\times {10}^6$	$6.85\times {10}^3$			$3.18\times {10}^2$	$3.01\times {10}^2$
2	(711)	36/137	18/168	14/142	12/133	13/55				16/169	18/203
	[12]	$3.43\times {10}^{19}$	$1.48\times {10}^3$	$1.05\times {10}^2$	$3.20\times {10}^2$	$5.92\times {10}^6$				$8.12\times {10}^3$	$8.12\times {10}^3$
3	(747)	23/137	15/168			14/55				18/169	19/203
	[15]	$3.58\times {10}^7$	$1.94\times {10}^2$			$1.20\times {10}^6$				$2.02\times {10}^3$	$4.78\times {10}^3$
4	(441)	50/137	15/168	19/142	18/133	6/55	19/193	7/78	12/151	9/169
	[10]	$2.92\times {10}^{45}$	$1.91\times {10}^4$	$3.97\times {10}^8$	$6.42\times {10}^8$	$2.49\times {10}^2$	$3.40\times {10}^6$	$2.74\times {10}^2$	$4.44\times {10}^3$	$1.29\times {10}^1$
5	(123)	9/137						8/78		6/169	8/203
	[23]	$2.97\times {10}^6$						$6.08\times {10}^7$		$4.29\times {10}^3$	$3.03\times {10}^4$
6	(292)	45/137	20/168	19/142	18/133	4/55	19/193	11/78	12/151
	[14]	$1.35\times {10}^{46}$	$3.32\times {10}^{11}$	$2.27\times {10}^{11}$	$4.00\times {10}^{11}$	$7.95\times {10}^2$	$2.24\times {10}^9$	$4.90\times {10}^7$	$4.87\times {10}^5$
7	(246)	40/137	9/168	10/142	9/133		11/193	4/78	7/151		6/203
	[6]	$5.61\times {10}^{42}$	$6.60\times {10}^3$	$5.80\times {10}^4$	$1.32\times {10}^3$		$1.16\times {10}^3$	$2.57\times {10}^1$	$6.31\times {10}^2$		$4.52\times {10}^1$
8	(873)	75/137	30/168	32/142	32/133		36/193	14/78	24/151	25/169
	[24]	$5.59\times {10}^{63}$	$2.09\times {10}^9$	$9.32\times {10}^{13}$	$1.89\times {10}^{13}$		$7.51\times {10}^{12}$	$1.39\times {10}^4$	$1.62\times {10}^6$	$3.11\times {10}^6$
9	(113)	18/137	11/168	12/142	10/133	6/55	12/193	4/78	11/151
	[20]	$8.24\times {10}^{18}$	$7.10\times {10}^8$	$1.66\times {10}^9$	$8.42\times {10}^8$	$8.85\times {10}^6$	$2.96\times {10}^8$	$6.64\times {10}^3$	$2.96\times {10}^8$
10	(104)	11/137	8/168	9/142	8/133	5/55	10/193		8/151
	[20]	$1.98\times {10}^8$	$6.68\times {10}^5$	$3.23\times {10}^6$	$1.71\times {10}^5$	$1.56\times {10}^4$	$3.23\times {10}^6$		$3.60\times {10}^5$
11	(120)	6/137		4/142		5/55					5/203
	[3]	$9.04\times {10}^3$		$8.49\times {10}^2$		$2.98\times {10}^3$					$6.83\times {10}^2$

(i) Ribosome: hsa03010; (ii) Alzheimer’s disease: hsa05010; (iii) Parkinson’s disease: hsa05012; (iv) Oxidative phosphorylation: hsa00190; (v) Pathogenic Escherichia coli infection:hsa05130; (vi) Huntington’s disease: hsa05016; (vii) Cardiac muscle contraction: hsa04260; (viii) Nonalcoholic fatty liver disease (NAFLD): hsa04932; (ix) Protein processing in endoplasmic reticulum: hsa04141; and (x) Proteoglycans in cancer: hsa05205. (numbers): gene; [numbers]: KEGG pathways. Upper rows in each exp: (the number of genes coinciding with the genes selected for each experiment)/(genes listed in Enrichr in each category). Lower rows in each exp: adjusted P-values provided by Enrichr.